QQ客服 官方微博 反馈留言

	Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial
	Guo, Ye; Shi, Mei; Yang, Ankui; Feng, Jifeng; Zhu, Xiaodong; Choi, Young-Jin; Hu, Guoqin; Pan, Jianji; Hu, Chunhong; Luo, Rongcheng
刊名	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
	2015
卷号	37期号:8
关键词	cetuximab Chinese EXTREME trial head and neck cancer recurrent and metastatic squamous cell carcinoma
ISSN号	1043-3074
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4869794
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Guo, Ye,Shi, Mei,Yang, Ankui,et al. Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial[J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,2015,37(8).
APA	Guo, Ye.,Shi, Mei.,Yang, Ankui.,Feng, Jifeng.,Zhu, Xiaodong.,...&Shi, yuankai.(2015).Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial.HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,37(8).
MLA	Guo, Ye,et al."Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial".HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 37.8(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。